Combined use of neutrophil to lymphocyte Ratio & C-reactive protein level to predict clinical outcomes in acute myocardial infarction patients undergoing percutaneous coronary intervention

Korean Circulation Journal

Volumn 47, Issue 3, 2017, Pages 383-391

  Shin, Ho Cheol ^a   Jang, Jae Sik ^a   Jin, Han Young ^a   Seo, Jeong Sook ^a   Yang, Tae Hyun ^a   Kim, Dae Kyeong ^a   Kim, Dong Soo ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Lymphocytes; Myocardial infarction; Neutrophils; Prognosis

Indexed keywords

C REACTIVE PROTEIN;

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; ARTICLE; CEREBROVASCULAR DISEASE; CLINICAL OUTCOME; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL LYMPHOCYTE RATIO; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RECURRENT DISEASE; STENT THROMBOSIS; SURVIVAL;

EID: 85020174580     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2016.0327     Document Type: Article

References (30)

1. Ross R. AtherosclerosisAn inflammatory disease. N Engl J Med 1999;340:115-26.
2. Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38.
3. Ogita M, Miyauchi K, Tsuboi S, et al. Impact of combined C-reactive protein and high-density lipoprotein cholesterol levels on long-Term outcomes in patients with coronary artery disease after a first percutaneous coronary intervention. Am J Cardiol 2015;116:999-1002.
4. Han YC, Yang TH, Kim DI, et al. Neutrophil to lymphocyte ratio predicts long-Term clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Korean Circ J 2013;43:93-9.
5. Gibson PH, Croal BL, Cuthbertson BH, et al. Preoperative neutrophillymphocyte ratio and outcome from coronary artery bypass grafting. Am Heart J 2007;154:995-1002.
6. Gibson PH, Cuthbertson BH, Croal BL, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91.
7. Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. The combined use of the neutrophil-lymphocyte ratio and C-reactive protein level as prognostic predictors in adult patients with soft tissue sarcoma. J Surg Oncol 2013;108:481-5.
8. O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2013;127:e362-e425.
9. Amsterdam EA, Wenger NK, Brindis RG, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2014;64:e139-e228.
10. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007;115:2344-51.
11. Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short-And long-Term mortality after non-ST-elevation myocardial infarction. Am J Cardiol 2010;106:470-6.
12. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS. Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008;102:653-7.
13. Fowler AJ, Agha RA. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiographyThe growing versatility of NLR. Atherosclerosis 2013;228:44-5.
14. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
15. Forman MB, Puett DW, Virmani R. Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol 1989;13:450-9.
16. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefinedA consensus document of the joint european society of cardiology/american college of cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000;36:959-69.
17. De Servi S, Mariani M, Mariani G, Mazzone A. C-reactive protein increase in unstable coronary disease cause or effect? J Am Coll Cardiol 2005;46:1496-502.
18. Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med 2015;278:483-93.
19. Agrawal A, Gang TB, Rusinol AE. Recognition functions of pentameric C-reactive protein in cardiovascular disease. Mediators Inflamm 2014;2014:319215.
20. Deftereos S, Giannopoulos G, Angelidis C, et al. Anti-inflammatory treatment with colchicine in acute myocardial infarction: A pilot study. Circulation 2015;132:1395-403.
21. Ugur M, Gul M, Bozbay M, et al. The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention. Blood Coagul Fibrinolysis 2014;25:806-11.
22. Temiz A, Gazi E, Gungor O, et al. Platelet/lymphocyte ratio and risk of in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit 2014;20:660-5.
23. Sari I, Sunbul M, Mammadov C, et al. Relation of neutrophil-Tolymphocyte and platelet-To-lymphocyte ratio with coronary artery disease severity in patients undergoing coronary angiography. Kardiol Pol 2015;73:1310-6.
24. Cho KI, Ann SH, Singh GB, Her AY, Shin ES. Combined usefulness of the platelet-To-lymphocyte ratio and the neutrophil-To-lymphocyte ratio in predicting the long-Term adverse events in patients who have undergone percutaneous coronary intervention with a drugeluting stent. PLoS One 2015;10:e0133934.
25. Helmers C. Short and long-Term prognostic indices in acute myocardial infarction. A study of 606 patients initially treated in a coronary care unit. Acta Med Scand Suppl 1973;555:7-26.
26. Kelly TL, Gilpin E, Ahnve S, Henning H, Ross J Jr. Smoking status at the time of acute myocardial infarction and subsequent prognosis. Am Heart J 1985;110:535-41.
27. Sparrow D, Dawber TR. The influence of cigarette smoking on prognosis after a first myocardial infarction. A report from the Framingham study. J Chronic Dis 1978;31:425-32.
28. Weinblatt E, Shapiro S, Frank CW, Sager RV. Prognosis of men after first myocardial infarction: mortality and first recurrence in relation to selected parameters. Am J Public Health Nations Health 1968;58:1329-47.
29. Aune E, Roislien J, Mathisen M, Thelle DS, Otterstad JE. The "smoker's paradox" in patients with acute coronary syndrome: A systematic review. BMC Med 2011;9:97.
30. Misumida N, Kobayashi A, Kanei Y. Racial differences in the neutrophil-To-lymphocyte ratio in patients with non-ST-segment elevation myocardial infarction. Coron Artery Dis 2015;26:381-5.